Boehringer Ingelheim (Canada) Ltd.
Registration:
1
of
1
(2011-01-14
to
2011-08-26)
Federal Government institutions who will be communicated with
-
Foreign Affairs and International Trade Canada (DFAITC)
-
Health Canada (HC)
-
House of Commons
-
Industry Canada
-
Patented Medicine Prices Review Board (PMPRB)
-
Prime Minister's Office (PMO)
-
Senate of Canada